PATENT CLAIM ANALYSIS

Application Number: 15773928
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "139000"]

Abstract:
The present invention relates to a pharmaceutical composition for prevention or treatment of a neuroinflammatory disease, in which the pharmaceutical composition includes a protein tyrosine phosphatase inhibitor. The protein tyrosine phosphatase inhibitor of the present invention inhibits activated microglia by decreasing the level of nitric oxide (NO) in the microglia and reducing the expression of proinflammatory factors, such as TNFα, IL1β, and iNOS, thereby being favorably used in prevention or treatment of the neuroinflammatory disease.

Claim (Index 4):
The pharmaceutical composition for prevention or treatment of a neuroinflammatory disease according to  claim 1 , wherein the neuroinflammatory disease is selected from the group consisting of multiple sclerosis, neuroblastoma, stroke, Alzheimer's disease, Parkinson's disease, Lou Gehrig's disease, Huntington's disease, Creutzfeldt Jakob disease, post-traumatic stress disorder, depression, schizophrenia, and amyotrophic lateral sclerosis.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 95.0
- Lexical Diversity: 1.68
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15495841', '15577398', '14688014', '15577417', '13266659']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8054178388837723
- 35 USC 102 Novelty (BERT): 0.5009732159352561
- Combined Prediction Score: 0.7749733765889207
- Mean Citation Score: 249.159784
- Max Citation Score: 267.82016
- Similarity Product: 204.7861916426849

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test